NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 6.310
- -0.140-2.17%
Close Feb 26 16:00 ET
- 6.350
- +0.040+0.63%
Post 20:01 ET
534.23MMarket Cap-2.57P/E (TTM)
6.630High6.220Low1.32MVolume6.560Open6.450Pre Close8.39MTurnover2.17%Turnover RatioLossP/E (Static)84.66MShares16.50052wk High1.05P/B384.27MFloat Cap4.30552wk Low--Dividend TTM60.90MShs Float78.000Historical High--Div YieldTTM6.36%Amplitude4.305Historical Low6.360Avg Price1Lot Size
About Verve Therapeutics Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sekar Kathiresan, M.D.
- Chief Executive Officer and Director
- 9.32M
- Dr. Ourania Tatsis, PhD
- Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
- --
- Troy Lister, PhD
- Chief Scientific Officer
- --
- Andrew D. Ashe, J.D.
- President and Chief Operating Officer
- --
- Joan Nickerson
- Chief Administrative Officer
- --
- Allison Dorval
- Chief Financial Officer and Principal Accounting Officer
- 3.48M
- Frederick Fiedorek, M.D.
- Chief Medical Officer
- --
- Dr. Burt A. Adelman, M.D.
- Chairman of the Board
- 451.88K
- Sheila Mikhail, J.D.
- Independent Director
- 412.38K
- Lonnel Coats
- Independent Director
- 407.38K
- Alexander G. Cumbo
- Independent Director
- 405.88K
- Michael F. Maclean
- Independent Director
- 521.07K
- Dr. Krishna Yeshwant, M.D.
- Independent Director
- 410.88K
- Jodie P. Morrison
- Independent Director
- --